Premium
Mid-market private equity firm Jacob Ballas Capital India Pvt. Ltd stands to make sub-par returns when it fully exits portfolio company Inventia Healthcare Ltd via an initial public offering (IPO). The Mumbai-based pharmaceutical development and manufacturing company has filed its draft prospectus with the Securities and Exchange Board of India (SEBI) ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
